{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:02:34Z","timestamp":1774540954822,"version":"3.50.1"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.rec.2025.10.012","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:39:14Z","timestamp":1761788354000},"page":"369-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current insights and challenges in the management of hyperkalemia"],"prefix":"10.1016","volume":"79","author":[{"given":"Carolina","family":"Ortiz-Cort\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Francisco","family":"Navarro-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2025.10.012_bib0455","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.kint.2019.09.018","article-title":"Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"97","author":"Clase","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.rec.2025.10.012_bib0460","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.nefro.2023.05.004","article-title":"Documento de consenso sobre el abordaje de la hiperpotasemia","volume":"43","author":"Ortiz","year":"2023","journal-title":"Nefrolog\u00eda."},{"key":"10.1016\/j.rec.2025.10.012_bib0465","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ckj\/sfab243","article-title":"How common is hyperkalaemia?. A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies","volume":"15","author":"Humphrey","year":"2022","journal-title":"Clin Kidney J."},{"key":"10.1016\/j.rec.2025.10.012_bib0470","first-page":"98","article-title":"Alteraciones graves del potasio plasm\u00e1tico: prevalencia, caracterizaci\u00f3n cl\u00ednica-electrocardiogr\u00e1fica y su pron\u00f3stico","volume":"56","author":"Rivera-Ju\u00e1rez","year":"2021","journal-title":"REC: CardioClinics."},{"key":"10.1016\/j.rec.2025.10.012_bib0475","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.recesp.2019.05.004","article-title":"Hyperkalemia in heart failure patients in Spain and its impact on guidelines and recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry","volume":"73","author":"Crespo-Leiro","year":"2020","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2025.10.012_bib0480","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ehf2.13164","article-title":"Frequency and clinical impact of hyperkalaemia within a large, modern, real-world heart failure population","volume":"8","author":"Muhlestein","year":"2021","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.rec.2025.10.012_bib0485","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000479802","article-title":"Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and\/or diabetes","volume":"46","author":"Collins","year":"2017","journal-title":"Am J Nephrol."},{"key":"10.1016\/j.rec.2025.10.012_bib0490","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1093\/ckj\/sfab076","article-title":"Hyperkalaemia management and related costs in chronic kidney disease patients with comorbidities in Spain","volume":"14","author":"De Labry Lima","year":"2021","journal-title":"Clin Kidney J."},{"key":"10.1016\/j.rec.2025.10.012_bib0495","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3390\/nu13061751","article-title":"Potassium Metabolism and Management in Patients with CKD","volume":"13","author":"Yamada","year":"2021","journal-title":"Nutrients."},{"key":"10.1016\/j.rec.2025.10.012_bib0500","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.nefro.2018.11.011","article-title":"Epidemiolog\u00eda de la hiperpotasemia en la enfermedad renal cr\u00f3nica","volume":"39","author":"Belmar Vega","year":"2019","journal-title":"Nefrolog\u00eda."},{"key":"10.1016\/j.rec.2025.10.012_bib0505","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.recesp.2023.05.004","article-title":"Prevalence and clinical profile of kidney disease in patients with chronic heart failure Insights from the Spanish cardiorenal registry","volume":"77","author":"Cobo Marcos","year":"2024","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2025.10.012_bib0510","doi-asserted-by":"crossref","DOI":"10.1001\/archinternmed.2009.132","article-title":"The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease","volume":"169","author":"Einhorn","year":"2009","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.rec.2025.10.012_bib0515","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijcard.2017.07.035","article-title":"Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system","volume":"245","author":"Nilsson","year":"2017","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2025.10.012_bib0520","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5500\/wjt.v11.i6.203","article-title":"Hyperkalemia: Major but still understudied complication among heart transplant recipients","volume":"11","author":"Singh","year":"2021","journal-title":"World J Transplant."},{"key":"10.1016\/j.rec.2025.10.012_bib0525","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ckj\/sfab129","article-title":"Prevalence and factors associated with hyperkalaemia in stable kidney transplant recipients","volume":"15","author":"Smyrli","year":"2022","journal-title":"Clin Kidney J."},{"key":"10.1016\/j.rec.2025.10.012_bib0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.cardfail.2019.07.532","article-title":"Incidence and Clinical Significance of Hyperkalemia Following Heart Transplantation","volume":"25","author":"Uriel","year":"2019","journal-title":"J Card Fail."},{"key":"10.1016\/j.rec.2025.10.012_bib0535","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.xkme.2021.01.005","article-title":"Hyperkalemia Management in Older Adults With Diabetic Kidney Disease Receiving Renin-Angiotensin-Aldosterone System Inhibitors: A Post Hoc Analysis of the AMETHYST-DN Clinical Trial","volume":"3","author":"Bakris","year":"2021","journal-title":"Kidney Med."},{"key":"10.1016\/j.rec.2025.10.012_bib0540","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2147\/CLEP.S253745","article-title":"Real-World Epidemiology of Potassium Derangements Among Chronic Cardiovascular Metabolic and Renal Conditions: A Population-Based Analysis","volume":"12","author":"Jim\u00e9nez-Marrero","year":"2020","journal-title":"Clin Epidemiol."},{"key":"10.1016\/j.rec.2025.10.012_bib0545","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/17512433.2023.2213888","article-title":"Optimization of potassium management in patients with chronic kidney disease and type 2 diabetes on finerenone","volume":"16","author":"Ortiz","year":"2023","journal-title":"Expert Rev Clin Pharmacol."},{"key":"10.1016\/j.rec.2025.10.012_bib0550","first-page":"1","article-title":"Abordaje de la hiperpotasemia persistente en pacientes con enfermedad renal cr\u00f3nica","volume":"1","author":"Torregrosa","year":"2019","journal-title":"Nefrolog\u00eda."},{"key":"10.1016\/j.rec.2025.10.012_bib0555","first-page":"287","article-title":"Recomendaciones Para El Manejo de La Hiperpotasemia En Urgencias","volume":"34","author":"\u00c1lvarez-Rodr\u00edguez","year":"2022","journal-title":"Emergencias."},{"key":"10.1016\/j.rec.2025.10.012_bib0560","doi-asserted-by":"crossref","first-page":"e008912","DOI":"10.1161\/JAHA.118.008912","article-title":"Elevated Potassium Levels in Patients With Congestive Heart Failure: Occurrence","volume":"7","author":"Thomsen","year":"2018","journal-title":"Risk Factors, and Clinical Outcomes. J Am Heart Assoc."},{"key":"10.1016\/j.rec.2025.10.012_bib0565","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13941","article-title":"Risk factors associated with the incidence and recurrence of hyperkalaemia in patients with cardiorenal conditions","volume":"75","author":"Tafesse","year":"2021","journal-title":"Int J Clin Pract."},{"key":"10.1016\/j.rec.2025.10.012_bib0570","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1007\/s12325-024-02835-8","article-title":"Hyperkalemia Recurrence Following Medical Nutrition Therapy in Patients with Stage 3-4 Chronic Kidney Disease: The REVOLUTIONIZE I Real-World Study","volume":"41","author":"Rowan","year":"2024","journal-title":"Adv Ther."},{"key":"10.1016\/j.rec.2025.10.012_bib0575","doi-asserted-by":"crossref","DOI":"10.1177\/2054358120965838","article-title":"Polysulfonate Resins in Hyperkalemia: A Systematic Review","volume":"7","author":"Wong","year":"2020","journal-title":"Can J Kidney Health Dis."},{"key":"10.1016\/j.rec.2025.10.012_bib0580","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4212\/cjhp.v68i4.1469","article-title":"Effectiveness of Sodium Polystyrene Sulfonate for Short-Term Treatment of Hyperkalemia","volume":"68","author":"Batterink","year":"2015","journal-title":"Can J Hosp Pharm."},{"key":"10.1016\/j.rec.2025.10.012_bib0585","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/ndt\/gfz150","article-title":"Initiation of sodium polystyrene sulphonate and the risk of gastrointestinal adverse events in advanced chronic kidney disease: a nationwide study","volume":"35","author":"Laureati","year":"2020","journal-title":"Nephrol Dials Transplant."},{"key":"10.1016\/j.rec.2025.10.012_bib0590","first-page":"1025","article-title":"Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age. JAMA Intern Med","volume":"179","author":"Noel","year":"2019"},{"key":"10.1016\/j.rec.2025.10.012_bib0595","first-page":"102","article-title":"Cation Exchange Resins and colonic perforation","volume":"16","author":"Rodr\u00edguez-Luna","year":"2015","journal-title":"What surgeons need to know. Int J Surg Case Rep."},{"key":"10.1016\/j.rec.2025.10.012_bib0600","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMicm2205643","article-title":"Calcium Polystyrene Sulfonate\u2013Related Colonic Necrosis","volume":"388","author":"Chan","year":"2023","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2025.10.012_bib0605","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2215\/CJN.12651018","article-title":"Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia","volume":"14","author":"Spinowitz","year":"2019","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.rec.2025.10.012_bib0610","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000504078","article-title":"Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE","volume":"50","author":"Roger","year":"2019","journal-title":"Am J Nephrol."},{"key":"10.1016\/j.rec.2025.10.012_bib0615","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium Zirconium Cyclosilicate in Hyperkalemia","volume":"372","author":"Packham","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2025.10.012_bib0620","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejim.2023.08.022","article-title":"Novel potassium binders to optimize RAASi therapy in heart failure: A systematic review and meta-analysis","volume":"119","author":"Paolillo","year":"2024","journal-title":"Eur J Intern Med."},{"key":"10.1016\/j.rec.2025.10.012_bib0625","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae083","article-title":"Maintained renin\u2013angiotensin\u2013aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort study","volume":"17","author":"Rastogi","year":"2024","journal-title":"Clin Kidney J."},{"key":"10.1016\/j.rec.2025.10.012_bib0630","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1007\/s12325-023-02518-w","article-title":"Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study","volume":"40","author":"Agiro","year":"2023","journal-title":"Adv Ther."},{"key":"10.1016\/j.rec.2025.10.012_bib0635","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1007\/s12325-023-02631-w","article-title":"Impact of Sodium Zirconium Cyclosilicate Plus Renin\u2013Angiotensin\u2013Aldosterone System Inhibitor Therapy on Short-Term Medical Costs in Hyperkalemia: OPTIMIZE II Real-World Study","volume":"40","author":"Dwyer","year":"2023","journal-title":"Adv Ther."},{"key":"10.1016\/j.rec.2025.10.012_bib0640","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"New Engl J Med."},{"key":"10.1016\/j.rec.2025.10.012_bib0645","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1093\/eurheartj\/ehac401","article-title":"Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial","volume":"43","author":"Butler","year":"2022","journal-title":"Eur Heart J."},{"issue":"sup1","key":"10.1016\/j.rec.2025.10.012_bib0650","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/21556660.2019.1658287","article-title":"Patiromer and maintenance of RAASi therapy in hyperkalemic medicare patients","volume":"8","author":"Desai","year":"2019","journal-title":"J Drug Assess."},{"key":"10.1016\/j.rec.2025.10.012_bib0655","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.rec.2025.10.012_bib0660","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJM199604113341502","article-title":"Effect of the Angiotensin-Converting\u2013Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency","volume":"334","author":"Maschio","year":"1996","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2025.10.012_bib0665","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2025.10.012_bib0670","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2025.10.012_bib0675","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2025.10.012_bib0680","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.nefro.2022.08.007","article-title":"Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain","volume":"43","author":"de Sequera","year":"2023","journal-title":"Nefrologia."},{"key":"10.1016\/j.rec.2025.10.012_bib0685","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2025.10.012_bib0690","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease","volume":"99","author":"Cheung","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.rec.2025.10.012_bib0695","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2025.10.012_bib0700","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11739-023-03427-0","article-title":"Recommendations for the management of hyperkalemia in patients receiving renin\u2013angiotensin\u2013aldosterone system inhibitors","volume":"19","author":"De Nicola","year":"2024","journal-title":"Intern Emerg Med."},{"key":"10.1016\/j.rec.2025.10.012_bib0705","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/ehjcvp\/pvy015","volume":"4","author":"Rosano","year":"2018","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"key":"10.1016\/j.rec.2025.10.012_bib0710","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.nefro.2024.02.006","article-title":"Coste-efectividad del ciclosilicato de sodio y zirconio para el tratamiento de la hiperpotasemia en pacientes con enfermedad renal cr\u00f3nica o insuficiencia cardiaca en Espa\u00f1a","volume":"44","author":"Alc\u00e1zar-Arroyo","year":"2024","journal-title":"Nefrolog\u00eda."},{"key":"10.1016\/j.rec.2025.10.012_bib0715","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: A Meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.rec.2025.10.012_bib0720","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-8587(19)30256-6","article-title":"SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"7","author":"Neuen","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.rec.2025.10.012_bib0725","first-page":"1460","article-title":"Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People with Type 2 Diabetes: A Meta-Analysis of Individual Participant Data from Randomized","volume":"145","author":"Neuen","year":"2022","journal-title":"Controlled Trials. Circulation."},{"key":"10.1016\/j.rec.2025.10.012_bib0730","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.rec.2025.10.012_bib0735","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2215\/CJN.0000000000000205","article-title":"Influence of SGLT2i and RAASi and Their Combination on Risk of Hyperkalemia in DKD: A Network Meta-Analysis","volume":"18","author":"Luo","year":"2023","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.rec.2025.10.012_bib0740","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/s41591-024-03264-4","article-title":"Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes","volume":"30","author":"Vaduganathan","year":"2024","journal-title":"Nat Med."},{"key":"10.1016\/j.rec.2025.10.012_bib0745","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2025.10.012_bib0750","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1517\/13543784.2015.1059819","article-title":"Finerenone: third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease","volume":"24","author":"Liu","year":"2015","journal-title":"Expert Opin Investig Drugs."},{"key":"10.1016\/j.rec.2025.10.012_bib0755","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jamacardio.2024.4539","article-title":"Finerenone Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction","volume":"10","author":"Vardeny","year":"2025","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.rec.2025.10.012_bib0760","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jchf.2024.05.003","article-title":"Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia: REALIZE-K Design and Baseline Characteristics","volume":"12","author":"Kosiborod","year":"2024","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.rec.2025.10.012_bib0765","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1093\/eurheartj\/ehac401","article-title":"Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial","volume":"43","author":"Butler","year":"2022","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2025.10.012_bib0770","first-page":"1","article-title":"Opciones terap\u00e9uticas futuras para el tratamiento de la hiperpotasemia cr\u00f3nica","volume":"1","author":"Manrique","year":"2019","journal-title":"Monogr Nefrol."},{"key":"10.1016\/j.rec.2025.10.012_bib0775","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/acem.13954","article-title":"Emergency Potassium Normalization Treatment Including Sodium Zirconium Cyclosilicate: A Phase II, Randomized, Double-blind","volume":"27","author":"Peacock","year":"2020","journal-title":"Placebo-controlled Study (ENERGIZE). Acad Emerg Med."},{"key":"10.1016\/j.rec.2025.10.012_bib0780","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071311","volume":"13","author":"Rafique","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.rec.2025.10.012_bib0785","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41581-023-00784-z","article-title":"Differences in the epidemiology, management and outcomes of kidney disease in men and women","volume":"20","author":"Chesnaye","year":"2024","journal-title":"Nat Rev Nephrol."},{"key":"10.1016\/j.rec.2025.10.012_bib0790","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3724\/SP.J.1263.2011.00015","article-title":"Gender differences in the etiology of heart failure: A systematic review","volume":"8","author":"Nahid","year":"2011","journal-title":"J Geriatr Cardiol."},{"key":"10.1016\/j.rec.2025.10.012_bib0795","first-page":"289","article-title":"Are women more susceptible to ischemic heart disease compared to men?. A literature overview","volume":"18","author":"Majidi","year":"2021","journal-title":"J Geriatr Cardiol."},{"key":"10.1016\/j.rec.2025.10.012_bib0800","article-title":"Gender differences in cardiovascular disease","volume":"4","author":"Gao","year":"2019","journal-title":"Med Nov Technol Devices."},{"key":"10.1016\/j.rec.2025.10.012_bib0805","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s00125-023-05891-x","article-title":"Sex differences in type 2 diabetes","volume":"66","author":"Kautzky-Willer","year":"2023","journal-title":"Diabetologia."},{"key":"10.1016\/j.rec.2025.10.012_bib0810","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0009-8981(03)00112-8","article-title":"Gender and age as risk factors for hypokalemia and hyperkalemia in a multiethnic Asian population","volume":"331","author":"Hawkins","year":"2003","journal-title":"Clinica Chimica Acta."},{"key":"10.1016\/j.rec.2025.10.012_bib0815","article-title":"Gender-specific risk factors and outcomes of hyperkalemia in CKD patients: smoking as a driver of hyperkalemia in men","volume":"17","author":"Valdivielso","year":"2023","journal-title":"Clin Kidney J."},{"key":"10.1016\/j.rec.2025.10.012_bib0820","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1039\/D2SD00062H","article-title":"Point-of-care and self-testing for potassium: recent advances","volume":"1","author":"Hutter","year":"2022","journal-title":"Sens Diagn."},{"key":"10.1016\/j.rec.2025.10.012_bib0825","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1016\/j.ekir.2024.08.007","article-title":"Cost-Utility of Real-Time Potassium Monitoring in United States Patients Receiving Hemodialysis","volume":"9","author":"Bamforth","year":"2024","journal-title":"Kidney Int Rep."},{"key":"10.1016\/j.rec.2025.10.012_bib0830","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2215\/CJN.0000000000000483","article-title":"Validation of Noninvasive Detection of Hyperkalemia by Artificial Intelligence\u2013Enhanced Electrocardiography in High Acuity Settings","volume":"19","author":"Harmon","year":"2024","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.rec.2025.10.012_bib0835","article-title":"Mortality Risk Stratification Utilizing Artificial Intelligence Electrocardiogram for Hyperkalemia in Cardiac Intensive Care Unit Patients","volume":"3","author":"Harmon","year":"2024","journal-title":"JACC: Advances."},{"key":"10.1016\/j.rec.2025.10.012_bib0840","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41598-024-51468-y","article-title":"Machine learning models for early prediction of potassium lowering effectiveness and adverse events in patients with hyperkalemia","volume":"14","author":"Huang","year":"2024","journal-title":"Sci Rep."},{"key":"10.1016\/j.rec.2025.10.012_bib0845","year":"2023","journal-title":"The COVID-19 Pandemic and the Future of Telemedicine."},{"key":"10.1016\/j.rec.2025.10.012_bib0850","year":"2020","journal-title":"La raz\u00f3n por la que los m\u00e9dicos se deben adaptar a la nueva normalidad."},{"key":"10.1016\/j.rec.2025.10.012_bib0855","year":"2023","journal-title":"Estudio de Salud y Estilo de Vida."},{"key":"10.1016\/j.rec.2025.10.012_bib0860","year":"2021","journal-title":"Informe de Posicionamiento Terap\u00e9utico de Zirconium Ciclosilicato (Lokelma\u00ae) En El Tratamiento de La Hiperpotasemia."},{"key":"10.1016\/j.rec.2025.10.012_bib0865","year":"2019","journal-title":"Informe de Posicionamiento Terap\u00e9utico de Patiromer (Veltassa \u00ae) En El Tratamiento de La Hiperpotasemia.;"},{"key":"10.1016\/j.rec.2025.10.012_bib0870","doi-asserted-by":"crossref","DOI":"10.1177\/20543581211017408","article-title":"Initial and Recurrent Hyperkalemia Events in Patients With CKD in Older Adults: A Population-Based Cohort Study","volume":"8","author":"Sriperumbuduri","year":"2021","journal-title":"Can J Kidney Health Dis."},{"key":"10.1016\/j.rec.2025.10.012_bib0875","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/ndt\/gfab003","article-title":"Long-term mortality and trajectory of potassium measurements following an episode of acute severe hyperkalaemia","volume":"37","author":"Gorriz","year":"2022","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.rec.2025.10.012_bib0880","first-page":"273","article-title":"Hiperpotasemia en pacientes hospitalizados","volume":"34","author":"de Sequera","year":"2014","journal-title":"\u00bfC\u00f3mo evitarla?. Nefrologia."},{"key":"10.1016\/j.rec.2025.10.012_bib0885","first-page":"299","article-title":"Situaci\u00f3n actual de las unidades cardiorrenales en Espa\u00f1a","volume":"57","author":"Cobo Marcos","year":"2022","journal-title":"REC: CardioClinics."},{"key":"10.1016\/j.rec.2025.10.012_bib0890","year":"2012","journal-title":"KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease."},{"key":"10.1016\/j.rec.2025.10.012_bib0895","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3904\/kjim.2020.408","article-title":"Nutritional management in patients with chronic kidney disease","volume":"35","author":"Kim","year":"2020","journal-title":"Korean J Intern Med."},{"key":"10.1016\/j.rec.2025.10.012_bib0900","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11143970","article-title":"The \u201cFIFTY SHADOWS\u201d of the RALES Trial: Lessons about the Potential Risk of Dietary Potassium Supplementation in Patients with Chronic Kidney Disease","volume":"11","author":"Romero-Gonz\u00e1lez","year":"2022","journal-title":"J Clin Med."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585725002981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585725002981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:29:39Z","timestamp":1774538979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585725002981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1885585725002981"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2025.10.012","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current insights and challenges in the management of hyperkalemia","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2025.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2025.10.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}